Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation
Cancer. 2020 May 15;126(10):2279-2287. doi: 10.1002/cncr.32752.…
Agenesis of the septum pellucidum: Prenatal diagnosis and outcome
Prenat Diagn. 2020 May;40(6):674-680. doi: 10.1002/pd.5663. Epub…
Production of H2-Rich Syngas From Lignocellulosic Biomass Using Microwave-Assisted Pyrolysis Coupled With Activated Carbon Enabled Reforming
Front Chem. 2020 Jan 24;8:3. doi: 10.3389/fchem.2020.00003. eCollection…
Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients
Blood Cancer J. 2020 Feb 6;10(2):14. doi: 10.1038/s41408-020-0283-8.ABSTRACTMultiple…
Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells
J Clin Med. 2020 Jan 27;9(2):353. doi: 10.3390/jcm9020353.ABSTRACTTraditionally,…
EVI1 as a Prognostic and Predictive Biomarker of Clear Cell Renal Cell Carcinoma
Cancers (Basel). 2020 Jan 28;12(2):300. doi: 10.3390/cancers12020300.ABSTRACTThe…
Feasibility and agreement of including anterior-posterior complexes and landmarks of the proximal hemisphere into basic examination of the fetal brain: A prospective study
Prenat Diagn. 2020 Apr;40(5):596-604. doi: 10.1002/pd.5652. Epub…
New Insights into the Anterior Complex
Fetal Diagn Ther. 2020;47(6):514-518. doi: 10.1159/000504980.…
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Nat Genet. 2020 Jan;52(1):56-73. doi: 10.1038/s41588-019-0537-1.…
Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity
Aging (Albany NY). 2020 Jan 4;12(1):8-34. doi: 10.18632/aging.102646.…
Complete genome sequence of human T-cell lymphotropic type 1 from patients with different clinical profiles, including infective dermatitis
Infect Genet Evol. 2020 Apr;79:104166. doi: 10.1016/j.meegid.2019.104166.…
T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma
J Invest Dermatol. 2020 Jun;140(6):1253-1265. doi: 10.1016/j.jid.2019.11.014.…
